Mabwell (shanghai) Bioscience Co., Ltd.

This study tests a new drug called 7MW4911 in people with advanced colorectal or other gastrointestinal cancers that have not responded to standard treatments. The goal is to see if the drug is safe and can help shrink tumors. About 200 adults will take part in this early-phase t…

This study tests a new drug called 7MW4911 in 200 people with advanced solid tumors that have worsened after standard treatments. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. It is the first time this drug is being tested in human…

This study tests two experimental drugs, 7MW3711 and JS207, given together (with or without chemotherapy) in people with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety, find the best dose, and see if the combination can sl…

This study tests whether combining two drugs (9MW2821 and toripalimab) before and after surgery can improve outcomes for people with urothelial cancer (a type of bladder cancer). About 90 adults with non-spread cancer will receive the treatment and be monitored for tumor shrinkag…

This study tests an experimental drug called 9MW1911 in 360 adults with moderate-to-severe COPD. The goal is to see if it can reduce the number of serious flare-ups over one year compared to a placebo. Participants must be 40-75 years old, have had at least two moderate or one se…

This early-phase trial is testing a new drug called bulumtatug furvedotin (BFv) in 52 people with triple-negative breast cancer that has come back or spread to other parts of the body. Participants must have already received certain types of chemotherapy and antibody-drug conjuga…

This study tests an experimental drug called 9MW3811 in 30 adults with thick, raised scars that haven't improved in 6 months. The goal is to see if the drug can make scars look and feel better, and to check for side effects. Participants will receive either the drug or a placebo,…